Superbowl Ad Sparks A Healthy Controversy About Medication Safety
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Hims Super Bowl Ad Spotlights Weight-Loss Drug Copycats as Clock Ticks on Their Business
Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.
Millions Will See This Super Bowl Ad. Health Experts (and Two Senators) Aren’t Pleased.
The spot makes lofty claims about weight-loss drugs offered by the telehealth company Hims & Hers, but says little about ...
Super Bowl Ads Used To Be Great — Why Are They So Terrible Now?
Possibly the best of the celebrity ads was Dunkin’ Donuts ‘DunKings 2’ with Ben and Casey Affleck and a really terrific bit from Succession alum Jeremy Strong, leaning heavily into his reputation as a ...
Hims & Hers faces scrutiny from senators on Super Bowl ad that ‘risks misleading' patients
Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...
STAT13d
Ozempic approved for chronic kidney disease patients
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Is the promise of more affordable weight loss drugs too good to be true? Compounded semaglutide, explained.
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
Super Bowl ad sparks controversy over cut-rate Wegovy alternative
Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...